Understanding the Brick-and-Mortar Model of Stratum Corneum Structure

The Model's Origin and Enduring Influence

Elias's foundational research from the early 1980s established the brick-and-mortar model as the conceptual framework reframing the stratum corneum from an inert layer of dead cells into a structurally organized, functionally active permeability barrier.^[1] This model's enduring influence — still the standard reference framework in contemporary dermatological research over four decades later — reflects both its conceptual clarity and its continued mechanistic accuracy as subsequent research has refined, rather than overturned, its basic structural premise.^[4]

The "Bricks": Corneocyte Structure

Within this model, corneocytes — the terminally differentiated, anucleate keratinocytes discussed in the dedicated corneocyte review — function as the structural "bricks," providing mechanical resilience through their cornified envelope structure while remaining metabolically inert, consistent with their role as durable structural units rather than active cellular components.

The "Mortar": Lamellar Lipid Matrix

The "mortar" component consists of the continuous, extracellular lamellar lipid matrix — ceramides, cholesterol, and free fatty acids organized in the specific lamellar bilayer arrangement discussed throughout this literature — filling the intercellular spaces between corneocytes and providing the primary permeability barrier function through this lipid organization rather than through the corneocytes themselves.^[2]

Refinement Without Displacement

Van Smeden et al.'s more recent, biochemically detailed research on stratum corneum lipid organization has substantially refined understanding of the "mortar" component specifically — characterizing precise lamellar packing arrangements, ceramide subclass distribution, and the specific lipid ratios relevant to barrier function — without displacing or contradicting the foundational brick-and-mortar conceptual framework, illustrating how the model has accommodated four decades of increasingly granular research while retaining its explanatory core.^[3]

Clinical Translation: Formulation Strategy

Chamlin et al.'s clinical research on ceramide-dominant barrier repair formulation demonstrates the brick-and-mortar model's direct translation into effective clinical strategy: because the model correctly identifies the lipid "mortar" as the primary permeability-determining component, formulation science has appropriately focused ceramide-cholesterol-fatty acid replenishment as the central barrier-repair strategy, a translation from conceptual model to clinical practice validated by measured therapeutic outcomes.^[6] Draelos's cosmeceutical science review and Elias and Feingold's foundational lipid research reinforce this model-to-practice translation throughout the broader formulation literature.^[4,5]

Conclusion

The brick-and-mortar model, established through Elias's foundational research and refined but not displaced by four decades of subsequent biochemical research, remains the central, clinically validated conceptual framework for understanding stratum corneum structure — correctly identifying the lipid "mortar" as the primary target for effective barrier-repair formulation strategy. For questions on how this structural model informs your specific skincare needs, our pharmacist, Mine Ekber, is available for direct consultation via WhatsApp.

Frequently Asked Questions

Further Reading